A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?
New England Journal of Medicine · 2024
DOI: 10.1056/nejmms2312012 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Katie Watson. Beteiligte Einrichtung: From the Feinberg School of Medicine, Northwestern University, Chicago. Hauptthemen laut MEDLINE: Abortion, Induced, Mifepristone, Supreme Court Decisions, Abortifacient Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Feinberg School of Medicine, Northwestern University, Chicago.
Zitieren
APA
Watson, K. (2024). A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?. New England Journal of Medicine. https://doi.org/10.1056/nejmms2312012
Vancouver
Watson K. A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?. New England Journal of Medicine. 2024. doi:10.1056/nejmms2312012
BibTeX
@article{Watson2024,
author = {Watson, Katie},
title = {A Physician Attack on the FDA — Will the Supreme Court Reduce Access to Mifepristone?},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmms2312012}
}
EUVIMED